EP2127673 - PHARMACEUTICAL AGENT FOR PREVENTION AND TREATMENT OF SKIN DISEASE INDUCED BY ACCELERATED KERATINIZATION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 22.02.2013 Database last updated on 26.04.2025 | Most recent event Tooltip | 22.02.2013 | Application deemed to be withdrawn | published on 27.03.2013 [2013/13] | Applicant(s) | For all designated states Kyoto University 36-1 Yoshida-honmachi Sakyo-ku Kyoto-shi Kyoto 606-8501 / JP | [2009/49] | Inventor(s) | 01 /
TAKAHASHI, Kenzo c/o Graduate School of Medicine KYOTO UNIVERSITY Yoshida-konoecho Sakyo-ku Kyoto-shi Kyoto 606-8501 / JP | [2009/49] | Representative(s) | polypatent An den Gärten 7 51491 Overath / DE | [N/P] |
Former [2012/02] | Polypatent An den Gärten 7 51491 Overath / DE | ||
Former [2010/01] | Polypatent Postfach 40 02 43 51410 Bergisch Gladbach / DE | ||
Former [2009/49] | Polypatent Braunsberger Feld 29 51429 Bergisch Gladbach / DE | Application number, filing date | 08720365.9 | 07.03.2008 | [2009/49] | WO2008JP00479 | Priority number, date | JP20070059519 | 09.03.2007 Original published format: JP 2007059519 | [2009/49] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008111296 | Date: | 18.09.2008 | Language: | JA | [2008/38] | Type: | A1 Application with search report | No.: | EP2127673 | Date: | 02.12.2009 | Language: | EN | [2009/49] | Search report(s) | International search report - published on: | JP | 18.09.2008 | (Supplementary) European search report - dispatched on: | EP | 01.04.2010 | Classification | IPC: | A61K45/00, A61K31/231, A61P17/12, A61P29/00 | [2009/49] | CPC: |
A61K45/06 (EP,US);
A61K31/231 (EP,US);
A61P17/00 (EP);
A61P17/12 (EP);
A61P29/00 (EP)
| C-Set: |
A61K31/231, A61K2300/00 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2009/49] | Title | German: | PHARMAZEUTISCHES MITTEL ZUR PRÄVENTION UND BEHANDLUNG VON HAUTERKRANKUNGEN DURCH BESCHLEUNIGTE KERATINISIERUNG | [2009/49] | English: | PHARMACEUTICAL AGENT FOR PREVENTION AND TREATMENT OF SKIN DISEASE INDUCED BY ACCELERATED KERATINIZATION | [2009/49] | French: | AGENT PHARMACEUTIQUE POUR LA PRÉVENTION ET LE TRAITEMENT D'UNE MALADIE CUTANÉE INDUITE PAR UNE KÉRATINISATION ACCÉLÉRÉE | [2009/49] | Entry into regional phase | 18.09.2009 | Translation filed | 18.09.2009 | National basic fee paid | 18.09.2009 | Search fee paid | 18.09.2009 | Designation fee(s) paid | 18.09.2009 | Examination fee paid | Examination procedure | 18.09.2009 | Examination requested [2009/49] | 28.05.2010 | Amendment by applicant (claims and/or description) | 29.06.2010 | Despatch of a communication from the examining division (Time limit: M04) | 10.07.2010 | Reply to a communication from the examining division | 21.12.2010 | Despatch of a communication from the examining division (Time limit: M02) | 04.02.2011 | Reply to a communication from the examining division | 11.08.2011 | Despatch of a communication from the examining division (Time limit: M04) | 10.12.2011 | Reply to a communication from the examining division | 02.10.2012 | Application deemed to be withdrawn, date of legal effect [2013/13] | 07.11.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2013/13] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 29.06.2010 | Fees paid | Renewal fee | 15.03.2010 | Renewal fee patent year 03 | 15.03.2011 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.03.2012 | 05   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [L]US2004209959 (HOGESTATT EDWARD [SE], et al) [L] 1-5 * paragraph [0005] - paragraph [0006] *; | [E]WO2009012221 (UNIV TEXAS, et al) [E] 1-3 * paragraph [0157] * * paragraph [0007] * | [I] - MACCARRONE MAURO ET AL, "The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase.", THE JOURNAL OF BIOLOGICAL CHEMISTRY 5 SEP 2003, (20030905), vol. 278, no. 36, ISSN 0021-9258, pages 33896 - 33903, XP002574127 [I] 1-5 * abstract * * page 33896, column 1, line 3rd from bottom - page 33897, column 1, line 14 * * page 33902, column 2, paragraph 2 * DOI: http://dx.doi.org/10.1074/JBC.M303994200 | by applicant | JPH05345722 | JPH11500411 | JP2000256323 | WO0119807 | JP2001516361 | WO0210135 | WO02053543 | JP2003201250 | WO03075908 | WO2004091521 | JP2006160644 |